| 12466822 |
Heterocyclic compounds as immunomodulators |
Liangxing Wu, Neil Lajkiewicz, Chunhong He, Kaijiong Xiao, Weihao Zhu +3 more |
2025-11-11 |
|
| 12466815 |
Carboxamide compounds and uses thereof |
Oleg Vechorkin, Jun Pan, Alexander Sokolsky, Evan Styduhar, Qinda Ye |
2025-11-11 |
|
| 12466828 |
Bicyclic amines as CDK2 inhibitors |
Yingda Ye, Zhenzhong Li, Ding-Quan Qian, Sarah Winterton, Kaijiong Xiao +7 more |
2025-11-11 |
|
| 12441742 |
Naphthyridine compounds as inhibitors of KRAS |
Gencheng Li, Haolin Yin, Changhe Qi, Xilu Wang, Bitai Hu +1 more |
2025-10-14 |
|
| 12441731 |
Pyrazolopyrimidine compounds and uses thereof |
Oleg Vechorkin, Minh Tri Nguyen, Changhe Qi, Anlai Wang, Liangxing Wu +1 more |
2025-10-14 |
|
| 12441727 |
Tricyclic compounds as inhibitors of KRAS |
Pei Gan, Jeffrey Ming-Jer Yang, Youjia Li, Le Zhao, Chunhong He +2 more |
2025-10-14 |
|
| 12428420 |
Tricyclic heterocycles as FGFR inhibitors |
Robert Swyka, Evan Styduhar, Xin Li, Oleg Vechorkin |
2025-09-30 |
|
| 12384778 |
Pyrazolopyridine compounds and uses thereof |
Oleg Vechorkin, Jun Pan, Kai Liu, Alexander Sokolsky, Anlai Wang +2 more |
2025-08-12 |
|
| 12378243 |
Quinoline compounds as inhibitors of KRAS |
Qinda Ye, Matthew S. McCammant, Rocco Policarpo, Artem Shvartsbart, Wenyu Zhu +13 more |
2025-08-05 |
|
| 12331063 |
Hetero-bicyclic inhibitors of KRAS |
Alexander Sokolsky, Chang Min, Xiaozhao Wang |
2025-06-17 |
|
| 12312331 |
Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors |
Qinda Ye, Jingwei Li, Ken Mukai, Brandon Smith, Liangxing Wu +4 more |
2025-05-27 |
|
| 12247038 |
Pyrido[3,2-d]pyrimidine compounds as immunomodulators |
Jingwei Li, Liangxing Wu |
2025-03-11 |
|
| 12247026 |
Heterocyclic compounds as immunomodulators |
Liangxing Wu, Jingwei Li |
2025-03-11 |
|
| 12201636 |
Heterocyclylamines as PI3K inhibitors |
Yun-Long Li, Andrew P. Combs, Eddy W. Yue, Song Mei, Joseph Glenn +2 more |
2025-01-21 |
|
| 12187743 |
Heterocyclic compounds as immunomodulators |
Liangxing Wu, Kaijiong Xiao |
2025-01-07 |
|
| 12187725 |
Tricyclic urea compounds as JAK2 V617F inhibitors |
Yanran Ai, Yu Sheng Bai, Joseph Barbosa, Hao Feng, Leah C. Konkol +5 more |
2025-01-07 |
|
| 12129267 |
Heteroaryl amide compounds as sting activators |
Liangxing Wu, Neil Lajkiewicz |
2024-10-29 |
$111,860,000 |
| 12122767 |
Bicyclic heterocycles as FGFR inhibitors |
Oleg Vechorkin, Hai Fen Ye |
2024-10-22 |
$84,741,000 |
| 12084449 |
Imidazotriazines and imidazopyrimidines as kinase inhibitors |
Jincong Zhuo, Meizhong Xu, Chunhong He, Colin Zhang, Ding-Quan Qian +3 more |
2024-09-10 |
|
| 12083124 |
Bicyclic heterocycles as FGFR inhibitors |
Oleg Vechorkin, Minh Ngoc Nguyen, Chao Qi, Anlai Wang, Michael Witten +4 more |
2024-09-10 |
$19,871,000 |
| 12077539 |
Imidazole and triazole KRAS inhibitors |
Chao Qi, Xiaozhao Wang |
2024-09-03 |
$81,309,000 |
| 12060433 |
CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy |
Horacio G. Nastri, Shaun M. Stewart, Juan Carlos Almagro, Jing Zhou, Rebecca A. Buonpane +9 more |
2024-08-13 |
$73,572,000 |
| 12030883 |
Hetero-tricyclic compounds as inhibitors of KRAS |
Peter Carlsen, Ken Mukai, Haolin Yin, Xiaozhao Wang, Wenyu Zhu |
2024-07-09 |
$15,981,000 |
| 12030884 |
Pyrazoloquinoline KRAS inhibitors |
Wenyu Zhu, Xiaozhao Wang |
2024-07-09 |
$15,981,000 |
| 12030889 |
Imidazopyridazine and imidazopyridine compounds and uses thereof |
Jun Pan, Jeremy Roach, Song Mei, Chunhong He, Liangxing Wu |
2024-07-09 |
$15,981,000 |
